FDA Withdraws Approval of 36 Watson Laboratories, Inc. ANDAs

Summary

The US Food and Drug Administration (FDA) has withdrawn the approval of 36 abbreviated new drug applications (ANDAs) from Watson Laboratories, Inc. and other applicants, following a written notification that the drug products are no longer commercially available.